Literature DB >> 6812964

In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor.

E A Grimm, A Mazumder, S A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6812964     DOI： 10.1016/0008-8749(82)90326-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.

Authors:  R E Merchant; M D Ellison; H F Young
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

2.  Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.

Authors:  E Kedar; E Chriqui-Zeira; S Mitelman
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

5.  Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody.

Authors:  T Kikuchi; M Watanabe; T Ohno
Journal:  Jpn J Cancer Res       Date:  1991-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.